Now showing items 1-1 of 1
Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq
(BioMed Central Ltd., 2020-12-03)
Background: Alternative splicing isoforms have been reported as a new and robust class of diagnostic biomarkers. Over 95% of human genes are estimated to be alternatively spliced as a powerful means of producing functionally ...